Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Comparing Life Sciences Consultancies: EvoLV vs. Local Competitors

Jul 07, 2026By Sreejith Kanhirangadan

SK

Introduction to Life Sciences Consultancies

In the rapidly evolving field of life sciences, consultancies play a crucial role in providing expert guidance to companies aiming to innovate and grow. Whether you're a startup or an established pharmaceutical giant, selecting the right consultancy can significantly impact your success. This blog post compares EvoLV with local competitors, helping you make an informed decision.

life sciences consulting

Core Competencies of EvoLV

EvoLV stands out for its specialized focus on life sciences. They offer a comprehensive range of services, including market analysis, regulatory compliance, and strategic planning. Their team of experts is known for blending scientific knowledge with business acumen, providing clients with actionable insights that drive growth.

One of EvoLV's strengths is its ability to customize solutions based on the unique challenges faced by each client. This tailored approach ensures that every strategy is aligned with the client's goals and industry standards.

Expertise and Experience

With years of experience in the industry, EvoLV’s consultants bring a wealth of knowledge to the table. Their deep understanding of the latest scientific advancements and regulatory changes ensures that clients are always a step ahead. Furthermore, their proven track record of successful projects underscores their capability to deliver results.

business team meeting

Local Competitors in the Life Sciences Sector

Local consultancies often have the advantage of understanding regional markets and regulations. These firms may provide more personalized services and quicker responses, which can be crucial for businesses operating on tight timelines. However, they may lack the specialized focus and global perspective that larger firms like EvoLV offer.

When considering local competitors, it's important to evaluate their expertise in specific areas of life sciences. While some may excel in biotechnology, others might be more proficient in pharmaceuticals or medical devices.

Comparing Service Offerings

When comparing EvoLV and local competitors, consider the diversity of services offered. EvoLV provides a broad spectrum of services that cover every aspect of life sciences consulting. In contrast, local firms might focus on niche areas, offering depth in specific fields but lacking the comprehensive approach of larger consultancies.

consulting services

Cost Considerations

Budget is often a critical factor in choosing a consultancy. Larger firms like EvoLV might have higher fees due to their extensive resources and expertise. However, the value they provide can outweigh the costs, especially for complex projects that require a high level of expertise and strategic insight.

Local consultancies may offer more competitive pricing, making them an attractive option for smaller companies or those with limited budgets. It's essential to weigh the cost against the potential benefits and long-term value each consultancy can deliver.

Making the Right Choice

Ultimately, the choice between EvoLV and local competitors should be based on your specific needs, goals, and resources. Consider factors such as expertise, service offerings, cost, and the ability to provide tailored solutions. By thoroughly evaluating these aspects, you can select a consultancy that will best support your growth and innovation in the life sciences industry.

business decision making